Workflow
RCM Technologies(RCMT)
icon
Search documents
RCM Technologies(RCMT) - 2021 Q3 - Earnings Call Transcript
2021-11-12 19:21
Financial Data and Key Metrics Changes - The company's revenue grew by over $13.9 million year-over-year, representing an increase of approximately 44% compared to Q3 2020, while sequentially decreasing by $1.9 million after adjusting for the Canada Power Systems divestiture [15] - Adjusted EBITDA for Q3 2021 was $1.9 million, reflecting a year-over-year increase of about 780% from $0.2 million in Q3 2020 [12][15] - Gross profit increased to $12.1 million, a 38% rise over Q3 2020 and a 15% increase over Q3 2019 [16] Business Line Data and Key Metrics Changes - The Health Care Services (HCS) segment generated revenue of $19.6 million in Q3 2021, marking a 118% increase year-over-year, although it decreased by $3.3 million compared to Q2 2021 [11][17] - The IT division reported revenue of $9.3 million in Q3 2021, up from $7.5 million in Q3 2020 and $9.1 million in Q2 2021, indicating strong performance [18] - The Engineering Division generated revenue of $16.0 million in Q3 2021, showing growth both sequentially and year-over-year [19] Market Data and Key Metrics Changes - The demand for health care professionals remains robust, particularly from school districts for testing and nursing personnel, contributing to the strong performance of the health care segment [12][41] - The Engineering division is optimistic about its backlog and pipeline as it heads into 2022, with several new client wins anticipated [19] Company Strategy and Development Direction - The company aims to become a world-class services organization by embracing digital transformation and modernizing its solutions for a digital-first world [6][13] - Investments are being prioritized to revamp the company's digital architecture and enhance CRM capabilities, which are expected to facilitate a digital-first go-to-market strategy [7][9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about operational momentum continuing into Q4 2021 and beyond, particularly in the health care segment [12][41] - The company anticipates a material uptick in net debt towards the high end of its target range of 1 to 2x EBITDA as it enters its strongest seasonal quarter [13] Other Important Information - The company ended Q3 with a favorable net debt position of $5.1 million, primarily due to proceeds from the sale of Canadian assets [12] - Management highlighted the importance of leveraging technology to fulfill its vision and improve operational efficiency [7][8] Q&A Session Summary Question: Health care performance relative to expectations - Management noted strength across all businesses, with strong demand for health care professionals and significant testing revenue contributing to the upside [22][23] Question: Engineering pipeline outlook - Management expects a meaningful uptick in the Engineering group's performance, with optimism across all divisions, particularly in Aerospace [29][31] Question: Health care revenue breakdown - In Q3, approximately $10.1 million of health care revenue came from schools, while $9.5 million was from nonschool sources [37] Question: Margin sustainability - Management indicated that margins in health care are sustainable in the short term, with expectations for strong gross margins moving forward [40] Question: Potential shareholder rewards - Management discussed the board's ongoing consideration of capital allocation strategies, including potential rewards to shareholders, but indicated that a dividend is unlikely in the short term [54][55]
RCM Technologies(RCMT) - 2021 Q1 - Earnings Call Transcript
2021-05-14 18:54
RCM Technologies, Inc. (NASDAQ:RCMT) Q1 2021 Earnings Conference Call May 14, 2021 11:00 AM ET Company Participants Kevin Miller – Chief Financial Officer Brad Vizi – Executive Chairman Conference Call Participants Bill Sutherland – The Benchmark Company Alex Rygiel – B. Riley Securities Kevin Miller Good morning. And thank you for joining us. This is Kevin Miller, Chief Financial Officer of RCM technologies. I am joined today by Brad Vizi, RCMÂ's Executive Chairman. Our presentation in this call will conta ...
RCM Technologies(RCMT) - 2021 Q4 - Annual Report
2021-04-02 20:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 2, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ........... to ........... Commission file number 1-10245 RCM TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Inco ...
RCM Technologies(RCMT) - 2020 Q4 - Earnings Call Transcript
2021-04-02 16:54
RCM Technologies, Inc. (NASDAQ:RCMT) Q4 2020 Results Conference Call April 2, 2021 10:30 AM ET Company Participants Brad Vizi - Executive Chairman & President Kevin Miller - CFO, Treasurer & Secretary Conference Call Participants Bill Sutherland - The Benchmark Company Alex Rygiel - B. Riley Securities Operator Ladies and gentlemen, welcome to RCM Technologies Fourth Quarter Conference Call. Brad Vizi Good morning, everyone. This is Brad Vizi, Executive Chairman of RCM Technologies. Welcome to the RCM Techn ...
RCM Technologies(RCMT) - 2020 Q3 - Earnings Call Transcript
2020-11-10 20:36
RCM Technologies, Inc. (NASDAQ:RCMT) Q3 2020 Earnings Conference Call November 10, 2020 11:00 AM ET Company Participants Brad Vizi - Executive Chairman Kevin Miller - Chief Financial Officer Brad Vizi Good morning, everyone. This is Brad Vizi, Executive Chairman of RCM Technologies. Welcome to the RCM Technologies 2020 Third Quarter Earnings Call. I'm joined today by Kevin Miller, our Chief Financial Officer. Kevin will begin with a legal disclaimer, and then I will summarize the operating results for each ...
RCM Technologies(RCMT) - 2020 Q2 - Earnings Call Transcript
2020-08-11 18:10
RCM Technologies, Inc. (NASDAQ:RCMT) Q2 2020 Earnings Conference Call August 11, 2020 11:00 AM ET Company Participants Brad Vizi - Executive Chairman Kevin Miller - CFO Conference Call Participants Bill Sutherland - The Benchmark Company LLC Brad Vizi Good morning, everyone. This is Brad Vizi, Executive Chairman of RCM Technologies. Welcome to the RCM Technologies 2020 Second Quarter Earnings Call. I'm joined today by Kevin Miller, our Chief Financial Officer. Kevin will begin with a legal disclaimer, and t ...
RCM Technologies(RCMT) - 2020 Q1 - Earnings Call Transcript
2020-05-12 22:13
Financial Data and Key Metrics Changes - The company experienced a significant revenue impact across all three segments due to COVID-19, with a focus on maximizing cash flow and reducing debt [5][14] - The debt-to-EBITDA ratio for Q1 was reported at 4.4, which is higher than desired, but the company received a waiver from Citizens Bank [46][47] Business Line Data and Key Metrics Changes - The healthcare staffing segment lost approximately $3 million in revenue and over $1 million in gross profit due to school closures [8][9] - The engineering and IT segments were less impacted, with no material reduction in current assignments but a slowdown in new business inquiries [10][34] - The company has reduced SG&A expenses by more than $1.5 million annually in healthcare and nearly $2 million in engineering and IT [9][13] Market Data and Key Metrics Changes - The healthcare market is experiencing chaos, with high demand for nurses but challenges in execution [28] - There is cautious optimism regarding the engineering segment, with proposal activity in transmission and distribution (T&D) remaining decent [32][34] Company Strategy and Development Direction - The company is focused on cost and debt reduction while positioning itself for growth in a post-COVID world [14] - New opportunities are being explored, including COVID screening services and telehealth offerings for schools [25][29] Management Comments on Operating Environment and Future Outlook - Management acknowledges the challenges in visibility beyond Q2 but remains optimistic about pent-up demand for field services [11][34] - The company is committed to being cash flow positive in Q2 and Q3, emphasizing the importance of cash flow management [36] Other Important Information - The arbitration related to three major projects has been completed, with a potential cash inflow of $7.4 million expected in Q2 [49][60] - The company does not qualify for PPP funding due to its size [64] Q&A Session Summary Question: What is the current utilization rate in healthcare staffing? - The healthcare staffing business typically runs at nearly 100% utilization, but there was some bench time in March due to statutory requirements [18][20] Question: What is the outlook for the fall regarding furloughed staff? - It is expected that most furloughed staff will not return until the school season starts again in the fall [45] Question: How is the company managing its debt covenants? - The company received a waiver for Q1 and is confident in managing future waivers as long as it maintains positive cash flow [46][47] Question: What is the status of the arbitration settlement? - The arbitration is complete, and the company is hopeful to receive $7.4 million in cash in Q2 [49][60] Question: Does the company qualify for any PPP money? - The company does not qualify for PPP funding due to its size [64]
RCM Technologies(RCMT) - 2019 Q2 - Earnings Call Transcript
2019-08-12 21:13
Financial Data and Key Metrics Changes - RCM Technologies reported a second quarter revenue of $23.4 million in the specialty health care staffing group, a 3% increase compared to the same period in 2018 [4] - Engineering segment revenue declined by 14% year-over-year to $18.6 million [6] - Information technology group revenue increased by 20% year-over-year to $8.7 million [8] Business Line Data and Key Metrics Changes - Specialty health care staffing achieved a record revenue, with a 7% increase in revenue per school day compared to the first quarter of 2019 and a 17% increase compared to the second quarter of 2018 [4] - Engineering segment is expected to finish the year strong despite current softness, with new contracts anticipated to boost performance in 2020 [6][7] - IT group demonstrated strong growth due to a significant transformation in sales and management personnel, resulting in a 20% revenue increase [8] Market Data and Key Metrics Changes - The company is seeing increased demand in the life sciences space within the IT business, indicating a broader market opportunity [22] - The engineering segment is experiencing a pipeline of significant EPC opportunities, although the exact revenue guidance remains uncertain [16] Company Strategy and Development Direction - RCM Technologies is focused on enhancing its engineering business and positioning it for sustainable long-term results despite current revenue softness [7] - The company is investing in training and recruiting RBTs to capitalize on the new contract with the Hawaii Department of Education, which has an annual cap of $40 million [12][27] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the resilience of the company amid global uncertainties, highlighting the stable drivers of each business unit [3] - The company anticipates a gradual build-up in revenue from the new RBT contract, with more significant impacts expected in the fourth quarter and into 2020 [29] Other Important Information - The engineering segment's gross margin improved to 28%, attributed to better utilization and a shift away from lower-margin work [18][19] - The company is focused on reducing days sales outstanding (DSOs) and paying down debt, with a significant cash influx expected from an ongoing arbitration [32][35] Q&A Session Summary Question: Is there any improvement in permanent placements in healthcare? - Management noted no meaningful change in permanent placements, but remains encouraged by the team [10] Question: What is the outlook for the Hawaii contract? - The contract has a maximum annual value of $40 million, but the actual spending will depend on the number of RBTs that can be trained [25][27] Question: How is the engineering gross margin performing? - The gross margin of 28% is expected to be a typical target moving forward, with improvements due to better project management [18][19] Question: What is the expected revenue timeline for new engineering projects? - Revenue from the cannabis project is expected to be recognized by the end of the year, while the calcium chloride project may start generating revenue in early 2020 [20][21] Question: How is the IT business performing in terms of market demand? - The IT business is experiencing strong growth, particularly in life sciences, with opportunities for market share expansion [22] Question: What is the status of accounts receivables and debt reduction? - Management expressed disappointment in the progress of reducing receivables but expects positive cash flow in the upcoming quarters [32][35]
RCM Technologies(RCMT) - 2019 Q1 - Earnings Call Transcript
2019-05-11 03:48
RCM Technologies, Inc. (NASDAQ:RCMT) Q1 2019 Earnings Conference Call May 9, 2019 10:00 AM ET Company Participants Bradley Vizi - Executive Chairman Kevin Miller - CFO Conference Call Participants William Sutherland - The Benchmark Company Daniel Drawbaugh - B. Riley FBR Operator Good morning and welcome to the RCM Technologies, Inc. earnings conference call. Your host, Bradley, you may now begin. Bradley Vizi Good morning, everyone. This is Bradley Vizi, Executive Chairman of RCM Technologies. Welcome to t ...
RCM Technologies(RCMT) - 2018 Q4 - Earnings Call Transcript
2019-03-07 20:48
Financial Data and Key Metrics Changes - The fiscal 2018 adjusted EBITDA was $8.9 million, representing a growth of approximately 12% compared to fiscal 2017 [4] - The company reported a revenue of $23.1 million in Q4 2018, which is a 4.3% increase from Q4 2017 [5] - Fiscal 2018 revenue reached $83.7 million, exceeding fiscal 2017 by 17% [5] Business Line Data and Key Metrics Changes - The Specialty Healthcare Staffing Group achieved a record revenue of $23.1 million in Q4 2018, driven by school contracts which generated $16.2 million in Q4 2018, up from $14.7 million in Q4 2017 [5][6] - Revenue from school contracts for fiscal 2018 was $55.1 million, a growth of 36% from $40.5 million in the prior year [6] - The Locum Tenens business generated $1.5 million in revenue for 2018, up from $120,000 in 2017, while the HIM group saw revenue increase to $4.6 million from $3.9 million [7] - The permanent placement business underperformed, with fiscal 2018 revenue of approximately $1.5 million compared to $2.3 million in 2017 [7] Market Data and Key Metrics Changes - The engineering segment rebounded in Q4 2018 with revenue of $23.6 million, compared to $19.4 million in Q3 2018 and $21.2 million in Q4 2017 [10] - The information technology group reported revenue of $8.5 million in Q4 2018, the highest since Q2 2017, reflecting an 18% growth when accounting for divested units [15][16] Company Strategy and Development Direction - The company aims to continue investing in business development resources to enhance strategic client relationships and enter new geographic markets [13][14] - There is a focus on sustainable growth in engineering and monetizing core capabilities, with expectations for a strong second half of 2019 and an even better 2020 [15][18] - The company plans to prioritize debt repayment and seek low-risk acquisitions to support growth strategies [39][41] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for strong performance in fiscal 2019, despite potential softness in Q1 due to project timing and strong comparables from Q1 2018 [18] - The company anticipates improvements in gross margins and operating performance in 2019, particularly in healthcare and engineering [9][18] Other Important Information - The company expects to see a retroactive bill rate increase in New York City to address minimum wage increases, which should positively impact gross margins [9] - The Days Sales Outstanding (DSO) improved to approximately 86.2 days at year-end, down from 99.8 days in Q3 2018, with expectations for further improvement [33] Q&A Session Summary Question: How is the year expected to start? - Management expects healthcare to perform well, some softness in engineering, and decent revenues in IT, with payroll tax increases impacting margins [21][24] Question: Performance of Thermal Kinetics? - Thermal Kinetics contributed about $2.58 million in revenues in Q4 with a gross margin of roughly 27%, but their performance can be lumpy due to project timing [25] Question: Insights on Canadian Power Systems and Arrow Energy Services? - Weakness was noted in aerospace and power systems, but strong performance is expected from energy services and process industrial units [27] Question: Growth trajectory in healthcare? - While top-line growth in healthcare may not match 2018 levels, increases in bill rates and headcount are expected to drive gross profit growth [31][32] Question: DSO improvement? - DSO improved to 86.2 days, with expectations to maintain DSOs in the 80s, potentially reaching the high 70s after resolving arbitration issues [33][36] Question: Capital plans and debt management? - The primary focus is on paying down debt, with plans for strategic acquisitions once debt levels are more aligned with targets [39][41]